Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/14/2007 | EP0952843B1 Pharmaceutical formulations for sustained drug delivery |
11/14/2007 | EP0866654B1 Method for treating hepatitis virus infection |
11/14/2007 | EP0756628B1 Morphogenic protein-specific cell surface receptors and uses therefor |
11/14/2007 | EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality |
11/14/2007 | EP0587858B2 Protein formulation comprising growth hormone |
11/14/2007 | CN101072875A Novel cancer antigen peptide and the use thereof |
11/14/2007 | CN101072874A Aptamer regulated nucleic acids and uses thereof |
11/14/2007 | CN101072579A Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
11/14/2007 | CN101072578A Combination cancer immunotherapy with co-stimulatory molecules |
11/14/2007 | CN101072577A Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels |
11/14/2007 | CN101072576A Methods of inhibiting cell death or inflammation in a mammal |
11/14/2007 | CN101072575A Hcv ns3-ns4a protease inhibition |
11/14/2007 | CN101072572A Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
11/14/2007 | CN101072571A Compositions for treatment of ear infections |
11/14/2007 | CN101070546A Human LPL gene mutation body of resisting atheroscleorsis |
11/14/2007 | CN101070542A Intensified tubercle-resisting action of human interleukin 24 |
11/14/2007 | CN101070540A New dendritic cell co-stimulatory molecules |
11/14/2007 | CN101070350A Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin |
11/14/2007 | CN101070349A Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof |
11/14/2007 | CN101070344A G-csf receptor agonist antibodies and screening method therefor |
11/14/2007 | CN101070343A Vascular endothelial cell growth factor variants and uses thereof |
11/14/2007 | CN101070342A Balsm-pear-seed ribosome inactivated protein and its coding gene and use |
11/14/2007 | CN101070341A Antibacterial peptide without mutagenic action |
11/14/2007 | CN101070340A Hornet anti-bacterial peptide, its preparing method and use |
11/14/2007 | CN101069742A Pancreatic kininogenase tablet and preparing method |
11/14/2007 | CN101069741A Medical radiation-ray preventive spray agent |
11/14/2007 | CN100348618C Process for producing hydroxyalkyl starch derivatives |
11/14/2007 | CN100348615C Gene of restraining activation NF-kB and NFAT, and coded polypeptide |
11/14/2007 | CN100348614C Idiosyncratic antigen protein, and antigen peptide of liver cancer orchis pellet |
11/14/2007 | CN100348267C Purification of red blood cells by separation and infiltration |
11/14/2007 | CN100348266C Peptide antagonists of zonulin and methods for use of the same |
11/14/2007 | CN100348265C Controlled release composition and method of producing the same |
11/13/2007 | US7294713 Antisense IAP oligonucleotides and uses thereof |
11/13/2007 | US7294712 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
11/13/2007 | US7294710 High-affinity choline transporter |
11/13/2007 | US7294708 Telomerase reverse transcriptase fragments and uses thereof |
11/13/2007 | US7294706 Fibroblast growth factor polypeptide for identifying modulators for treatment of tumor neovascularization and diabetic retinopathy; wound healing agents; angiogenesis activator |
11/13/2007 | US7294705 Anti-PRO3580 antibodies |
11/13/2007 | US7294703 Vectors with DNA encoding pro polypeptides |
11/13/2007 | US7294702 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/13/2007 | US7294700 Anti-PRO846 antibodies |
11/13/2007 | US7294699 Factor vii or factor ix polypeptides; enhanced membrane binding; blood disorders; blood coagulation |
11/13/2007 | US7294698 An isolated Archipelin polypeptide |
11/13/2007 | US7294697 Short chain neurotoxin from sea snake-Lapemis hardwickii and genes encoding the neurotoxin |
11/13/2007 | US7294693 Pro4428 Polypeptides |
11/13/2007 | US7294692 Vectors with DNA encoding pro polypeptides |
11/13/2007 | US7294689 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies |
11/13/2007 | US7294687 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject |
11/13/2007 | US7294652 Autoimmune conditions and NADPH oxidase defects |
11/13/2007 | US7294622 Lactams and uses thereof |
11/13/2007 | US7294617 Method for nonsurgical treatment of the intervertebral disc and kit therefor |
11/13/2007 | US7294616 Capreomycin derivatives and their use as antibacterials |
11/13/2007 | US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
11/13/2007 | US7294613 Beta-defensins |
11/13/2007 | US7294510 Propagating neuronal stem cells in nutrient broth comprising hedgehog, fibroblast growth factor and noggin proteins; for treatment of amyotrophic lateral sclerosis, huntington's chorea and alzheimer's disease; tissue engineering |
11/13/2007 | US7294504 For suppressing the expression of a gene targets and for degrading a target RNA using DNA as a vehicle |
11/13/2007 | US7294497 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms |
11/13/2007 | US7294496 Cloned human lysophospholipase |
11/13/2007 | US7294495 PR03580 polypeptides |
11/13/2007 | US7294477 Allergen and treatment |
11/13/2007 | US7294475 Gene and use thereof |
11/13/2007 | US7294473 Methods of identifying substances that interact with JTT-1 protein |
11/13/2007 | US7294472 Method for identifying modulators of G protein coupled receptor signaling |
11/13/2007 | US7294459 Cell regulatory genes, encoded products, and uses related thereto |
11/13/2007 | US7294455 Fixed-dried platelets cross-linked to protein |
11/13/2007 | US7294352 Matrix protein composition for treating inflammation |
11/13/2007 | US7294339 Method for treating allodynia by peripheral administration of a neurotoxin |
11/13/2007 | US7294334 Methods and compositions to treat myocardial conditions |
11/13/2007 | US7294333 Modifying the electrophysiological function of the heart and treating atrial fibrillation or ventricular tachycardia by implanting allogeneic or autogeneic fibroblasts expressing an exogenous voltage-gated or inward-rectifier potassium ion channel polypeptide into the heart |
11/13/2007 | US7294332 Combination therapy (temozolomide and α-IFN) for advanced cancer |
11/13/2007 | US7294331 Methods of using flt3-ligand in hematopoietic cell transplantation |
11/13/2007 | CA2333469C Myotilin, an actin-organizing protein |
11/13/2007 | CA2318398C Novel peptides having biological activity |
11/13/2007 | CA2292965C Pyrrolidine derivative hair growth compositions and uses |
11/13/2007 | CA2285574C Method and composition for treating sleep apnea |
11/13/2007 | CA2283637C Upar mimicking peptide |
11/13/2007 | CA2251008C Macromolecular complexes for drug delivery |
11/13/2007 | CA2241171C Product derived from milk substantially free of beta casein from non-human mammals and relative use |
11/13/2007 | CA2226142C Purification of dalbaheptide antibiotics by isoelectric focusing |
11/13/2007 | CA2222680C Endoparasiticidal agents |
11/13/2007 | CA2006813C Purified ciliary neurotrophic factor |
11/09/2007 | CA2589295A1 Characterization of c19orf10, a novel synovial protein |
11/08/2007 | WO2007127965A1 Treating glaucoma, cardiovascular diseases, and renal diseases |
11/08/2007 | WO2007127935A1 Dephosphorylation of hdac7 by myosin phosphatase |
11/08/2007 | WO2007127841A2 Compositions and methods of preparation thereof |
11/08/2007 | WO2007127839A2 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
11/08/2007 | WO2007127837A2 Microspheroidal-controlled release of biomolecules |
11/08/2007 | WO2007127813A2 Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds |
11/08/2007 | WO2007127803A2 Administration of growth factors for the treatment of cns disorders |
11/08/2007 | WO2007127667A1 Augmentation of titer for vaccination in animals |
11/08/2007 | WO2007127457A2 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
11/08/2007 | WO2007127439A2 Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
11/08/2007 | WO2007127231A2 Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof |
11/08/2007 | WO2007127207A2 Fixed combination dosage forms for the treatment of migraine |
11/08/2007 | WO2007127198A2 Protein crosslinkers, crosslinking methods and applications thereof |
11/08/2007 | WO2007127173A2 Therapeutic compounds |
11/08/2007 | WO2007127145A2 Methods and compositions for treatment of cardiac arrhythmia in non-human animals |
11/08/2007 | WO2007126950A1 Parenteral low dose type 1 interferons for bladder cancer |
11/08/2007 | WO2007126849A1 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals |
11/08/2007 | WO2007126832A2 Pharmaceutical compositions for prevention of overdose or abuse |